Spot Trading L.L.C - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 87 filers reported holding CTI BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
Spot Trading L.L.C ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2015$42,000
-16.0%
34,2780.0%0.00%
Q3 2015$50,000
-26.5%
34,2780.0%0.00%
Q2 2015$68,000
-4.2%
34,278
-12.7%
0.00%
Q1 2015$71,000
+69.0%
39,278
+161.9%
0.00%
Q2 2014$42,00015,0000.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2015
NameSharesValueWeighting ↓
EAGLE ASSET MANAGEMENT INC 15,707,022$38,010,0000.11%
First Heartland Consultants, Inc. 74,624$181,0000.08%
WASHINGTON TRUST Co 410,616$994,0000.07%
Geduld E E 40,000$97,0000.07%
FIRST NEW YORK SECURITIES LLC /NY 30,562$73,960,0000.05%
Crosspoint Capital Strategies, LLC 25,000$61,0000.04%
JANE STREET GROUP, LLC 1,434,975$3,473,0000.04%
MAGEE THOMSON INVESTMENT PARTNERS LLC 21,479$51,0000.01%
TIAA CREF TRUST CO FSB/MO 296,322$717,0000.01%
Investors Capital Advisory Services 16,950$41,0000.01%
View complete list of CTI BIOPHARMA CORP shareholders